- IPA Joins Indiana Coalition for Patient-Centered Care (ICPCC)
- HB-1246: Gabapentin INSPECT Clarification
HB-1246: Gabapentin INSPECT Clarification
By IPA on 6/24/2019
This recently signed 2019 bill intended gabapentin to be a “controlled substance” for the purposes of INSPECT only (and not outside of INSPECT). We have confirmed with the Indiana Board of Pharmacy that is how they have interpreted the law- it is not scheduled, just as to be reported.